Li Wan, Zhang Tianpeng, Ye Yanghuan, Zhang Xingwang, Wu Baojian
Division of Pharmaceutics, College of Pharmacy, Jinan University, 601 West Huangpu Avenue, Guangzhou 510632, PR China.
Division of Pharmaceutics, College of Pharmacy, Jinan University, 601 West Huangpu Avenue, Guangzhou 510632, PR China.
Int J Pharm. 2015 Nov 30;495(2):948-55. doi: 10.1016/j.ijpharm.2015.10.011. Epub 2015 Oct 20.
Chemotherapy via the oral route remains a considerable challenge due to poor water-solubility and permeability of anticancer agents. This study aimed to construct lipid nanoparticles using broccoli-derived lipids for oral delivery of tripterine (Tri), a natural anticancer candidate, and to enhance its oral bioavailability. Tri-loaded broccoli lipid nanoparticles (Tri-BLNs) were prepared by a solvent-diffusion method. The resulting Tri-BLNs were 75±10 nm in particle size with entrapment efficiency over 98%. In vitro release study indicated that Tri was almost not released from Tri-BLNs (<2%), whereas the lipolytic experiment showed that Tri-BLNs possessed a relatively strong anti-enzymatic degradation ability to Tri-CLNs (Tri-loaded common lipid nanoparticles). In situ single-pass intestinal perfusion manifested that the effective permeability of Tri-BLNs were significantly higher than that of Tri-CLNs. Further, Tri-BLNs exhibited more efficient cellular uptake in MDCK-II cells as evidenced by flow cytometry and confocal microscopy. The relative bioavailability of Tri-BLNs and Tri-CLNs was 494.13% and 281.95% compared with Tri suspensions, respectively. Depending on the ability in enhancement of biomembrane permeability, broccoli-derived lipids as an alternative source should be useful to construct lipid nanoparticles for bettering oral delivery of drugs with low bioavailability.
由于抗癌药物的水溶性和渗透性较差,口服化疗仍然是一个巨大的挑战。本研究旨在利用西兰花衍生的脂质构建脂质纳米颗粒,用于口服天然抗癌候选药物雷公藤红素(Tri),并提高其口服生物利用度。采用溶剂扩散法制备了负载雷公藤红素的西兰花脂质纳米颗粒(Tri-BLNs)。所得Tri-BLNs的粒径为75±10 nm,包封率超过98%。体外释放研究表明,Tri几乎不从Tri-BLNs中释放(<2%),而脂解实验表明,Tri-BLNs对负载雷公藤红素的普通脂质纳米颗粒(Tri-CLNs)具有相对较强的抗酶降解能力。原位单通道肠道灌注表明,Tri-BLNs的有效渗透率显著高于Tri-CLNs。此外,流式细胞术和共聚焦显微镜证实,Tri-BLNs在MDCK-II细胞中表现出更高效的细胞摄取。与Tri混悬液相比,Tri-BLNs和Tri-CLNs的相对生物利用度分别为494.13%和281.95%。基于增强生物膜通透性的能力,西兰花衍生的脂质作为一种替代来源,应用于构建脂质纳米颗粒以改善低生物利用度药物的口服给药应该是有用的。
Int J Nanomedicine. 2012-8-20
Pharmaceutics. 2021-5-20
Int J Nanomedicine. 2019-11-13